← Evidence map

ArticleOncogene2005

BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin.

Artur Slupianek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

this papercites it

BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin. | OpenQuestion